Medical News

RSS

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

Medtronic, Inc. today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI SureScan pacing system.

From Medtronic 1 Aug 2011

First Edition: August 1, 2011

In today's headlines, the early details regarding how the politics and policies involved of the debt-ceiling deal are taking shape.

1 Aug 2011

Vanda, Biotoscana Farma partner to commercialize Fanapt in Argentina

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced its exclusive license agreement with Argentina-based Biotoscana Farma S.A., a wholly owned affiliate of Biotoscana International, based in Bogota, Colombia, for the commercialization of Fanapt ™ in Argentina.

1 Aug 2011

Mobile health software effectively helps manage diabetes

An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.

1 Aug 2011

Widespread, institutional corruption in American science, scientist says

FDR's dream of the benefits of post-WWII government-supported civilian science over time has become a nightmare, according to scientist J. Marvin Herndon, in an article published in The Dot Connector magazine which exposes the widespread, institutional corruption of American science and traces its origin to the flawed methodologies invented in the 1950s by the National Science Foundation and in use at virtually all U.S. government science-funding agencies.

1 Aug 2011

CBIZ enters definitive agreement to acquire Multiple Benefit Services

CBIZ, Inc. today announced that it has signed a definitive agreement to acquire Multiple Benefit Services, Inc. effective August 1, 2011.

1 Aug 2011

Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.

1 Aug 2011

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

ARIAD Pharmaceuticals, Inc. today announced that its ridaforolimus partner, Merck, has submitted a marketing authorization application (MAA) for ridaforolimus with the European Medicines Agency.

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

BGI, the world's largest genomics organization, and GT Life Sciences, Inc., a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, announced today that their collaborative study on the genomic sequence of the Chinese hamster ovary (CHO) K1 cell line was published July 31, 2011 online in Nature Biotechnology.

1 Aug 2011

Mon General Hospital to install Merge cardiology and information solutions

Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that Mon General Hospital, one of West Virginia's leading acute-care community hospitals, located in Morgantown, is installing its full suite of enterprise-level cardiology solutions.

1 Aug 2011

SXC to launch enhanced Coordination of Benefits service in the state Medicaid market

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, is launching the industry's first automated, enhanced Coordination of Benefits service in the State Fee-For-Service Medicaid market.

1 Aug 2011

Artificial nanoparticles have direct effect on heart rate and rhythm

Artificial nanoparticles are becoming increasingly pervasive in modern life. However, their influence on our health and the mechanisms by which they affect the human body remain largely shrouded in mystery.

1 Aug 2011

Electrochem launches new company website and corporate brand

Electrochem Solutions, Inc. announced today the launch of its rebranded and redesigned company website.

1 Aug 2011

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs, presented its lead clinical candidate, Bendavia, during the 2011 American Heart Association's (AHA) Cardiovascular Scientific Sessions.

1 Aug 2011

Affymetrix to commercialize four Axiom genotyping arrays for the major populations

Affymetrix, Inc. today announced plans to commercialize four Axiom population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation's largest and most diverse genomics projects funded by the National Institutes of Health.

1 Aug 2011

Tips for obtaining life insurance after heart attack

Life Quotes, Inc. wants heart attack survivors to know that, while it may be tough to get a life insurance policy, it's not impossible. Heart disease is the #1 cause of death in America and many survivors are unaware of the life insurance options that may be open to them.

1 Aug 2011

Fischer retains TransMedia to launch Israel's most popular sunscreen in the U.S.

Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.

1 Aug 2011

Researchers identify new plasma membrane sculpting protein

The research group of Professor Pekka Lappalainen at the Institute of Biotechnology, University of Helsinki, has identified a previously unknown mechanism which modifies the structure of plasma membranes in intestinal epithelial cells.

1 Aug 2011